Physician profile
Robert E Cole
NPI 1043274632
$8,468.17
in general payments reported to CMS, 2019-2025
8 companies · $77.84 in 2025
The $77.84 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.80 · 2020: $19.18 · 2022: $237 · 2023: $8,047 · 2024: $71.44 · 2025: $77.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,500 · Travel and Lodging: $1,493 · Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,500.00 |
| Travel and Lodging | $1,492.92 |
| Food and Beverage | $202.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,029.92 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abiomed | $201.16 | 2022-2024 | Impella |
| Davol INC. | $76.95 | 2022 | |
| Smith+Nephew, INC. | $52.86 | 2025 | Na, Bone Anchors With Arthroscopic Delivery System, Intellio Link Werewolf |
| Avanos Medical | $47.32 | 2023-2024 | On-Q* Pump and Accessories |
| Heron Therapeutics, INC. | $24.98 | 2025 | Zynrelef |
| Abbott Laboratories | $19.18 | 2020 | |
| Covidien Lp | $15.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.